DMAA
Drugs Made In America Acquisition Corp.
NASDAQ · Financial Services · Shell Companies · US
$10.87
+0.09%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- 0.01x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.36x
- Net debt / EBITDA
- -0.35x
Liquidity & coverage
- Current ratio
- 0.02x
- Quick ratio
- 0.02x
- Cash ratio
- 0.01x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- -$2.9M
Cash & dividend
- FCF / debt
- -0.34x
- Cash flow / debt
- -0.34x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026